Deep Dive: Deep Dive Into Patient Experience During Clinical Trials

CAR-T cell therapy has dramatically changed the game for many cancer types. Recent findings in a trial examining a second-line CAR-T therapy option for large B-cell lymphoma showed a potential to shift the standard of care. In an interview with CURE®, Joseph McGuirk, D.O., discussed the inspiring ways in which CAR-T therapy advancements are transforming the cancer landscape.